vs

Side-by-side financial comparison of CareDx, Inc. (CDNA) and Hut 8 Corp. (HUT). Click either name above to swap in a different company.

CareDx, Inc. is the larger business by last-quarter revenue ($117.7M vs $88.5M, roughly 1.3× Hut 8 Corp.). CareDx, Inc. runs the higher net margin — 2.4% vs -316.0%, a 318.4% gap on every dollar of revenue. On growth, Hut 8 Corp. posted the faster year-over-year revenue change (179.2% vs 39.0%). Over the past eight quarters, Hut 8 Corp.'s revenue compounded faster (30.8% CAGR vs 12.9%).

CareDx, Inc. is a leading precision medicine company dedicated to organ transplant patient care. It develops and commercializes diagnostic tests for rejection surveillance, digital health management tools, and supportive clinical services, catering to transplant clinicians, patients, and healthcare systems across North America and European core markets.

Tropical Hut is a Filipino chain of fast food restaurants owned by Mercury Group of Companies, Inc. It is the 7th oldest food chain in the Philippines and older than Jollibee (1978) and McDonald's Philippines (1981).

CDNA vs HUT — Head-to-Head

Bigger by revenue
CDNA
CDNA
1.3× larger
CDNA
$117.7M
$88.5M
HUT
Growing faster (revenue YoY)
HUT
HUT
+140.2% gap
HUT
179.2%
39.0%
CDNA
Higher net margin
CDNA
CDNA
318.4% more per $
CDNA
2.4%
-316.0%
HUT
Faster 2-yr revenue CAGR
HUT
HUT
Annualised
HUT
30.8%
12.9%
CDNA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CDNA
CDNA
HUT
HUT
Revenue
$117.7M
$88.5M
Net Profit
$2.8M
$-279.7M
Gross Margin
60.4%
Operating Margin
1.0%
-491.4%
Net Margin
2.4%
-316.0%
Revenue YoY
39.0%
179.2%
Net Profit YoY
-283.7%
EPS (diluted)
$0.05
$-2.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDNA
CDNA
HUT
HUT
Q1 26
$117.7M
Q4 25
$108.4M
$88.5M
Q3 25
$100.1M
$83.5M
Q2 25
$86.7M
$41.3M
Q1 25
$84.7M
$21.8M
Q4 24
$86.6M
$31.7M
Q3 24
$82.9M
$43.7M
Q2 24
$92.3M
$35.2M
Net Profit
CDNA
CDNA
HUT
HUT
Q1 26
$2.8M
Q4 25
$-4.1M
$-279.7M
Q3 25
$1.7M
$50.1M
Q2 25
$-8.6M
$137.3M
Q1 25
$-10.4M
$-133.9M
Q4 24
$87.7M
$152.2M
Q3 24
$-10.6M
$647.0K
Q2 24
$-4.6M
$-71.9M
Gross Margin
CDNA
CDNA
HUT
HUT
Q1 26
Q4 25
60.4%
Q3 25
61.3%
Q2 25
47.3%
Q1 25
14.5%
Q4 24
35.9%
Q3 24
59.9%
Q2 24
41.4%
Operating Margin
CDNA
CDNA
HUT
HUT
Q1 26
1.0%
Q4 25
-5.6%
-491.4%
Q3 25
-0.2%
87.0%
Q2 25
-12.8%
Q1 25
-15.8%
-676.8%
Q4 24
97.5%
Q3 24
-16.6%
-3.6%
Q2 24
-7.9%
-246.2%
Net Margin
CDNA
CDNA
HUT
HUT
Q1 26
2.4%
Q4 25
-3.8%
-316.0%
Q3 25
1.7%
60.0%
Q2 25
-9.9%
332.5%
Q1 25
-12.2%
-613.7%
Q4 24
101.3%
480.3%
Q3 24
-12.8%
1.5%
Q2 24
-5.0%
-204.1%
EPS (diluted)
CDNA
CDNA
HUT
HUT
Q1 26
$0.05
Q4 25
$-0.08
$-2.45
Q3 25
$0.03
$0.43
Q2 25
$-0.16
$1.18
Q1 25
$-0.19
$-1.30
Q4 24
$1.60
$1.41
Q3 24
$-0.20
$0.01
Q2 24
$-0.09
$-0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDNA
CDNA
HUT
HUT
Cash + ST InvestmentsLiquidity on hand
$77.9M
$44.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
Total Assets
$411.1M
$2.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDNA
CDNA
HUT
HUT
Q1 26
$77.9M
Q4 25
$177.2M
$44.9M
Q3 25
$194.2M
$33.5M
Q2 25
$186.3M
$216.3M
Q1 25
$230.9M
$108.4M
Q4 24
$260.7M
$85.0M
Q3 24
$240.9M
Q2 24
$228.9M
Total Debt
CDNA
CDNA
HUT
HUT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$300.6M
Q3 24
$0
$297.3M
Q2 24
$0
$328.8M
Stockholders' Equity
CDNA
CDNA
HUT
HUT
Q1 26
Q4 25
$303.1M
$1.4B
Q3 25
$311.1M
$1.4B
Q2 25
$327.4M
$1.3B
Q1 25
$379.3M
$960.0M
Q4 24
$378.4M
$976.7M
Q3 24
$273.2M
$703.9M
Q2 24
$264.7M
$660.1M
Total Assets
CDNA
CDNA
HUT
HUT
Q1 26
$411.1M
Q4 25
$413.2M
$2.8B
Q3 25
$432.3M
$2.7B
Q2 25
$444.3M
$2.0B
Q1 25
$489.6M
$1.6B
Q4 24
$491.1M
$1.5B
Q3 24
$477.0M
$1.1B
Q2 24
$466.8M
$1.1B
Debt / Equity
CDNA
CDNA
HUT
HUT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.31×
Q3 24
0.00×
0.42×
Q2 24
0.00×
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDNA
CDNA
HUT
HUT
Operating Cash FlowLast quarter
$4.3M
$-139.2M
Free Cash FlowOCF − Capex
$514.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.54×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDNA
CDNA
HUT
HUT
Q1 26
$4.3M
Q4 25
$21.4M
$-139.2M
Q3 25
$37.4M
$770.0K
Q2 25
$9.9M
$-48.8M
Q1 25
$-26.6M
$-33.8M
Q4 24
$21.9M
$-68.5M
Q3 24
$12.5M
$-4.2M
Q2 24
$18.9M
$-16.4M
Free Cash Flow
CDNA
CDNA
HUT
HUT
Q1 26
$514.0K
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
FCF Margin
CDNA
CDNA
HUT
HUT
Q1 26
0.4%
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Cash Conversion
CDNA
CDNA
HUT
HUT
Q1 26
1.54×
Q4 25
Q3 25
22.30×
0.02×
Q2 25
-0.36×
Q1 25
Q4 24
0.25×
-0.45×
Q3 24
-6.49×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CDNA
CDNA

Financial Results Total$85.0M72%
Patient and digital solutions revenue$16.0M14%
Product revenue$10.3M9%
Other$6.4M5%

HUT
HUT

High Performance Computing Colocation And Cloud$81.9M93%
Power$5.0M6%
Digital Infrastructure$1.6M2%

Related Comparisons